Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


24.07.2017

1 BMJ
1 Infect Immun
1 J Immunol
5 J Virol
1 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
4 Pediatr Infect Dis J
9 PLoS One
9 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ

  1. MOBERLY T
    UK doctors re-examine case for mandatory vaccination.
    BMJ. 2017;358:j3414.
    PubMed     Text format    


    Infect Immun

  2. KUIPERS K, Jong WSP, van der Gaast-de Jongh CE, Houben D, et al
    Th17-mediated cross protection against pneumococcal carriage by vaccination with a variable antigen.
    Infect Immun. 2017 Jul 17. pii: IAI.00281-17. doi: 10.1128/IAI.00281.
    PubMed     Text format     Abstract available


    J Immunol

  3. TULLY CM, Chinnakannan S, Mullarkey CE, Ulaszewska M, et al
    Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge.
    J Immunol. 2017 Jul 19. pii: ji1600939. doi: 10.4049/jimmunol.1600939.
    PubMed     Text format     Abstract available


    J Virol

  4. ZHANG L, Li H, Hai Y, Yin W, et al
    CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells in
    J Virol. 2017;91.
    PubMed     Text format     Abstract available

  5. KUMAR J, Yadav VN, Phulera S, Kamble A, et al
    Species specificity of vaccinia virus complement control protein towards bovine classical pathway is governed primarily by direct interaction of its acidic residues with factor I.
    J Virol. 2017 Jul 19. pii: JVI.00668-17. doi: 10.1128/JVI.00668.
    PubMed     Text format     Abstract available

  6. SCOTT KA, Kotecha A, Seago J, Ren J, et al
    SAT2 Foot-and-Mouth Disease Virus Structurally Modified for Increased Thermostability.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available

  7. CHUANG GY, Geng H, Pancera M, Xu K, et al
    Structure-Based Design of a Soluble Prefusion-Closed HIV-1-Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.
    J Virol. 2017 Mar 8. pii: JVI.02268-16. doi: 10.1128/JVI.02268.
    PubMed     Text format     Abstract available

  8. LINGEMANN M, Liu X, Surman S, Liang B, et al
    Attenuated Human Parainfluenza Virus type 1 expressing Ebola Virus Glycoprotein GP Administered Intranasally is Immunogenic in African Green Monkeys.
    J Virol. 2017 Mar 1. pii: JVI.02469-16. doi: 10.1128/JVI.02469.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  9. HALSTEAD SB
    Achieving safe, effective, and durable Zika virus vaccines: lessons from dengue.
    Lancet Infect Dis. 2017 Jul 12. pii: S1473-3099(17)30362.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  10. LE DP, Vega J, Johnson LA
    Notes from the Field: Hospital Contact Investigation for a Patient Who Developed a Zoster Vaccine-Related Rash - Maryland, February 2015.
    MMWR Morb Mortal Wkly Rep. 2017;66:763-764.
    PubMed     Text format    


    N Engl J Med

  11. KAUR J, Puliyel J
    Heat-Stable Oral Rotavirus Vaccine.
    N Engl J Med. 2017;377:302.
    PubMed     Text format    


  12. Heat-Stable Oral Rotavirus Vaccine.
    N Engl J Med. 2017;377:302.
    PubMed     Text format    


    Pediatr Infect Dis J

  13. AGARKHEDKAR S, Juergens C, Balasundaram K, Agarkhedkar S, et al
    Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Children Aged 6 to 17 Years in India: An Open-Label Trial.
    Pediatr Infect Dis J. 2017 Jul 15. doi: 10.1097/INF.0000000000001695.
    PubMed     Text format     Abstract available

  14. LOPEZ P, Mohs AA, Vasquez AA, Consuelo-Miranda M, et al
    A Randomized, Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccinations of Healthy Infants and Toddlers in Latin America.
    Pediatr Infect Dis J. 2017 Jul 14. doi: 10.1097/INF.0000000000001682.
    PubMed     Text format     Abstract available

  15. TARTOF SY, Sy LS, Ackerson BK, Hechter RC, et al
    Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2-10 Years.
    Pediatr Infect Dis J. 2017 Jul 14. doi: 10.1097/INF.0000000000001696.
    PubMed     Text format     Abstract available

  16. OLARTE L, Romero J, Barson W, Bradley J, et al
    Osteoarticular Infections Caused by Streptococcus pneumoniae in Children in the Post Pneumococcal Conjugate Vaccine Era.
    Pediatr Infect Dis J. 2017 Jul 18. doi: 10.1097/INF.0000000000001697.
    PubMed     Text format     Abstract available


    PLoS One

  17. LORENZO MM, Sanchez-Puig JM, Blasco R
    Vaccinia virus and Cowpox virus are not susceptible to the interferon-induced antiviral protein MxA.
    PLoS One. 2017;12:e0181459.
    PubMed     Text format     Abstract available

  18. RICHARDSON S, Seekaew P, Koblin B, Vazquez T, et al
    Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City.
    PLoS One. 2017;12:e0181702.
    PubMed     Text format     Abstract available

  19. TIEN SH, Crabtree JN, Gray HL, Peterson EJ, et al
    Immunologic response to vaccine challenge in pregnant PTPN22 R620W carriers and non-carriers.
    PLoS One. 2017;12:e0181338.
    PubMed     Text format     Abstract available

  20. MOYO N, Borthwick NJ, Wee EG, Capucci S, et al
    Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens.
    PLoS One. 2017;12:e0181382.
    PubMed     Text format     Abstract available

  21. CARPENTIER AF, Geinguenaud F, Tran T, Sejalon F, et al
    Synthetic melanin bound to subunit vaccine antigens significantly enhances CD8+ T-cell responses.
    PLoS One. 2017;12:e0181403.
    PubMed     Text format     Abstract available

  22. CHEN X, Li N, Bi S, Wang X, et al
    Co-Activation of Th17 and Antibody Responses Provides Efficient Protection against Mucosal Infection by Group A Streptococcus.
    PLoS One. 2016;11:e0168861.
    PubMed     Text format     Abstract available

  23. KOMATSU H, Inui A, Umetsu S, Tsunoda T, et al
    Evaluation of the G145R Mutant of the Hepatitis B Virus as a Minor Strain in Mother-to-Child Transmission.
    PLoS One. 2016;11:e0165674.
    PubMed     Text format     Abstract available

  24. BUCHBINDER SP, Grunenberg NA, Sanchez BJ, Seaton KE, et al
    Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.
    PLoS One. 2017;12:e0179597.
    PubMed     Text format     Abstract available

  25. TSEKOA TL, Lotter-Stark T, Buthelezi S, Chakauya E, et al
    Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3.
    PLoS One. 2016;11:e0159313.
    PubMed     Text format     Abstract available


    Vaccine

  26. RUIZ-CONTRERAS J, Picazo J, Casado-Flores J, Baquero-Artigao F, et al
    Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children.
    Vaccine. 2017 Jul 12. pii: S0264-410X(17)30867.
    PubMed     Text format     Abstract available

  27. KOSTOVA EB, Poland GA
    Vaccinology in the 21st century-The 10th Annual Vaccine Congress.
    Vaccine. 2017 Jul 15. pii: S0264-410X(17)30911.
    PubMed     Text format    

  28. KELLY MJ, Foley D, Blackmore TK
    Hospitalised rotavirus gastroenteritis in New Zealand: The laboratory database is a valuable tool for assessing the impact of rotavirus vaccination.
    Vaccine. 2017 Jul 15. pii: S0264-410X(17)30914.
    PubMed     Text format     Abstract available

  29. CAMILLI R, D'Ambrosio F, Del Grosso M, de Araujo FP, et al
    Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
    Vaccine. 2017 Jul 14. pii: S0264-410X(17)30906.
    PubMed     Text format     Abstract available

  30. IRWIN KL, Jalloh MF, Corker J, Alpha Mahmoud B, et al
    Attitudes about vaccines to prevent Ebola virus disease in Guinea at the end of a large Ebola epidemic: Results of a national household survey.
    Vaccine. 2017 Jul 14. pii: S0264-410X(17)30803.
    PubMed     Text format     Abstract available

  31. MORCL T, Hurst BL, Tarbet EB
    Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice.
    Vaccine. 2017 Jul 14. pii: S0264-410X(17)30912.
    PubMed     Text format     Abstract available

  32. SARI TT, Akib AAP, Gatot D, Roswita Harahap A, et al
    Pneumococcal vaccination for splenectomized patients with thalassemia major in Indonesia.
    Vaccine. 2017 Jul 13. pii: S0264-410X(17)30907.
    PubMed     Text format     Abstract available

  33. CHAGUZA C, Cornick JE, Andam CP, Gladstone RA, et al
    Population genetic structure, antibiotic resistance, capsule switching and evolution of invasive pneumococci before conjugate vaccination in Malawi.
    Vaccine. 2017 Jul 12. pii: S0264-410X(17)30905.
    PubMed     Text format     Abstract available

  34. MADAN A, Collins H, Sheldon E, Frenette L, et al
    Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial.
    Vaccine. 2017 Jul 15. pii: S0264-410X(17)30909.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: